Furthermore, Acibucu et al. demonstrated even a decrease in sclerostin level during intramuscular therapy with 300.000 IU cholecalciferol injected monthly for 3 consecutive months in vitamin D deficient non-CKD patients [28]. This evidence concerns the gene SOST and chronic kidney disease.